ABBV
AbbVie Inc. · Healthcare
Insiders sold $17.7M of AbbVie Inc. in the last 12 months and bought none
ABBV over the last year
ABBV after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Congress
Members reported 98 trades in ABBV since 2023.
Every filing
129 insider filings since 2016, newest first
Nicholas Donoghoe · EVP, Chief Bus/strat Officer
Perry C Siatis · EVP, General Counsel and Secretary
Perry C Siatis · EVP, General Counsel and Secretary
Richard A Gonzalez · Executive Chair
Richard A Gonzalez · Executive Chair
Nicholas Donoghoe · EVP, Chief BUS, Strat Officer
Jeffrey Ryan Stewart · EVP and Chief Commercial Officer
Timothy J. Richmond · EVP and CHRO
Scott T Reents · EVP and CFO
Kevin K Buckbee · SVP, CONTROLLER
Robert A. Michael · President and COO
Perry C Siatis · EVP, General Counsel and Secretary
Richard A Gonzalez · Chair and CEO
Perry C Siatis · EVP, General Counsel and Secretary
Azita Saleki-Gerhardt · EVP and Chief Operations Officer
Nicholas Donoghoe · EVP, Chief BUS, Strat Officer
Richard A Gonzalez · Chair and CEO
Roxanne S Austin · Director
Elaine K. Sorg · SVP, US Commercial Operations
Elaine K. Sorg · SVP, US Commercial Operations
Elaine K. Sorg · SVP, US Commercial Operations
Perry C Siatis · EVP, General Counsel and Secretary
Jeffrey Ryan Stewart · EVP and Chief Commercial Officer
Azita Saleki-Gerhardt · EVP, Operations
Elaine K. Sorg · SVP, US Commercial Operations
Perry C Siatis · EVP, General Counsel and Secretary
Scott T Reents · EVP and CFO
Timothy J. Richmond · EVP and CHRO
Perry C Siatis · EVP, General Counsel and Secretary
Azita Saleki-Gerhardt · EVP, Operations
Roxanne S Austin · Director
Carrie C Strom · SVP, PRES Global Allerg Aesth
Elaine K. Sorg · SVP, US Commercial Operations
Timothy J. Richmond · EVP and CHRO
Michael Severino · Vice Chair
Henry O Gosebruch · EVP and Chief Strategy Officer
Henry O Gosebruch · EVP and Chief Strategy Officer
Michael Severino · Vice Chair
Michael Severino · Vice Chair
Jeffrey Ryan Stewart · EVP and Chief Commercial Officer
Brian L Durkin · VP, Controller
Henry O Gosebruch · EVP and Chief Strategy Officer
Henry O Gosebruch · EVP and Chief Strategy Officer
Jeffrey Ryan Stewart · EVP and Chief Commercial Officer
Robert A. Michael · Vice Chair
Carrie C Strom · SVP, Pres Global Allerg Aesth
Brian L Durkin · VP, Controller
Laura J Schumacher · Vice Chair
Jeffrey Ryan Stewart · EVP and Chief Commercial Officer
Elaine K. Sorg · SVP, US Commercial Operations
About AbbVie Inc.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.